1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow CADASIL: new trials by email Literature Review of CADASIL trials Research Report on CADASIL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CERebrolysin In CADASIL Cerebrolysin, 0.9 % NaCl - Cadasil | Phase 2 | Active not recruiting | Ever Neuro Pharma GmbH | 30 | 2023-11-29 | 2025-02-25 |
Brain Diseases (1) · Brain Infarction (1) · Brain Ischemia (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebral Arterial Diseases (1) · Cerebral Infarction (1) · Cerebral Small Vessel Diseases (1) · Cerebrovascular Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dementia (1) · Dementia, Vascular (1) · Genetic Diseases, Inborn (1) · Infarction (1) · Intracranial Arterial Diseases (1)
Sodium Chloride (1) · cerebrolysin (1)
Czechia (1)